Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PETMED EXPRESS INCPETS · Entity 7326 | Director | July 28, 2022 | August 01, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PETMED EXPRESS INC
Report date July 28, 2022 · Filed August 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,880 |
Reported balance
After 2022-07-28 transaction · row 1
1 source rowRow 1 · 2022-07-28 · Grant · Acquired 7,500 · Balance 18,880 F1: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Watson retains voting rights over all the shares while in escrow. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Watson retains voting rights over all the shares while in escrow.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2022 Filed Aug 1, 2022 17:58 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 7,500 | $21.76 | $163,200.00 |
DisclosureSEC source: 0001437749-22-018242 · rdgdoc.xml · nonDerivative · entry 1 Watson Jodi · CIK 0001866128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,880 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Watson retains voting rights over all the shares while in escrow. Read SEC document |
| January 11, 2022 Filed Jan 12, 2022 17:58 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 2,500 | $25.20 | $63,000.00 |
DisclosureSEC source: 0001437749-22-000764 · rdgdoc.xml · nonDerivative · entry 1 Watson Jodi · CIK 0001866128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,380 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Watson retains voting rights over all the shares while in escrow. Read SEC document |
| July 30, 2021 Filed Aug 4, 2021 15:04 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 7,500 | $31.39 | $235,425.00 |
DisclosureSEC source: 0001437749-21-018459 · rdgdoc.xml · nonDerivative · entry 1 Watson Jodi · CIK 0001866128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,880 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Watson retains voting rights over all the shares while in escrow. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.